Understanding obesity as a complex, inflammatory comorbidity in IBD
Obesity is increasingly recognized as a complex, inflammatory comorbidity in inflammatory bowel disease (IBD), with potential implications for disease activity, treatment response, and patient outcomes.
In this provider-focused episode, Gastro Girl host Jacqueline Gaulin speaks with Catherine Hudson, MD, of LSU Health New Orleans, about obesity as a complex, chronic disease and its relationship to IBD.
This episode explores the biological and metabolic factors that contribute to obesity, the relationship between obesity and inflammation, and important clinical considerations when obesity and IBD coexist. The discussion also highlights the importance of recognizing obesity as a chronic disease and approaching conversations about weight and health without stigma or blame.
Topics discussed include:
– Obesity as a complex, chronic disease and inflammatory comorbidity
– The relationship between obesity, inflammation, and IBD
– Biological and metabolic factors contributing to obesity
– Clinical considerations when obesity and IBD coexist
– The importance of compassionate, stigma-free communication
– Supporting individualized, patient-centered care
This episode is intended for healthcare professionals seeking to deepen their understanding of obesity in the context of IBD and support informed, shared decision-making with patients.
About This Educational Series
This episode is part of a 12-part Gastro Girl educational series, developed with support from Lilly, exploring the complex relationship between inflammatory bowel disease (IBD) and obesity/overweight. Featuring leading medical experts, the series examines emerging science, clinical considerations, and strategies to support informed, compassionate, patient-centered care.
This educational initiative is developed with support from Lilly.
Featured Videos
October 7, 2026
When IBD Treatment Isn’t Working: How to Know When It’s Time to Reassess
Living with inflammatory bowel disease (IBD) often means paying close attention to your symptoms and how well your treatment is controlling the disease. But what happens when you’re still having symptoms; or a treatment that once worked doesn’t seem to be working as well anymore? In this episode, Dr. Corey Siegel, an IBD specialist and Director of the Center for Digestive Health at Dartmouth Hitchcock Medical Center, joins us to explain how patients and their healthcare teamsa can recognize when an IBD treatment may not be achieving its goals and when it may be time to reassess the treatment plan. We discuss what successful IBD treatment can look like, why response to treatment may change over time, and how healthcare teams determine whether ongoing symptoms are caused by active IBD or something else. In this episode, you’ll learn: - What successful IBD treatment can look like - How long it may take to evaluate whether a treatment is working - Why a treatment that once worked may become less effective - How healthcare teams determine whether symptoms are caused by active IBD or something else - What treatment optimization means and when a different approach may be considered - Why your goals, concerns, and preferences matter when making treatment decisions with your healthcare team Dr. Siegel also explains why ongoing monitoring and open communication with your healthcare team are important and how shared decision-making can help patients and clinicians determine the next steps in IBD care. This episode was produced by Gastro Girl with support from Sanofi.
September 8, 2026
Living With IBD: What Remission Looks Like
For many people living with inflammatory bowel disease (IBD), understanding what remission actually means can be confusing. If your symptoms improve, does that mean your IBD is under control? And if you’re in remission, is the disease gone for good? In Part 2 of our conversation with IBD expert Dr. Jessica Allegretti, we explore what remission means in IBD and why feeling better is only one part of the picture. We discuss: - Clinical remission versus endoscopic remission - What mucosal healing means - The treat-to-target approach in IBD care - Why modern treatment goals focus on long-term disease control - How controlling inflammation may help reduce the risk of future complications Understanding both how you feel and what may be happening inside your body can help you have more informed conversations with your healthcare team and take an active role in managing your IBD. Subscribe to Gastro Girl for more expert-led conversations designed to help you navigate digestive health with confidence. This educational initiative is sponsored by Merck.
Let’s Keep in Touch!
Subscribe to get the latest news and content delivered straight to your inbox.
Listen to our
latest Podcast!